Clinical Trials Directory

Trials / Completed

CompletedNCT05216991

Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation

The Role of Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic device (EMG), such as TetraGraph.

Conditions

Interventions

TypeNameDescription
OTHERTetraGraph on dominant handUsing standard of care TetraGraph device on dominant hand
OTHERTetraGraph on non-dominant handUsing standard of care TetraGraph device on non-dominant hand

Timeline

Start date
2022-10-20
Primary completion
2025-01-21
Completion
2025-01-21
First posted
2022-02-01
Last updated
2025-10-24
Results posted
2025-10-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05216991. Inclusion in this directory is not an endorsement.